Kazia Therapeutics Limited
KZIA · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $2 | $5 | $7 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $4 | $5 | $2 |
| Total Curr. Assets | $5 | $6 | $11 | $9 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $15 | $17 | $19 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $7 |
| Total NC Assets | $1 | $15 | $17 | $26 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $6 | $22 | $28 | $36 |
| Liabilities | – | – | – | – |
| Payables | $6 | $5 | $1 | $2 |
| Short-Term Debt | $0 | $1 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $21 | $5 | $3 |
| Total Curr. Liab. | $14 | $26 | $8 | $7 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $2 | $2 | $3 |
| Other NC Liab. | $0 | $4 | $6 | $8 |
| Total NC Liab. | $0 | $6 | $8 | $11 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $14 | $32 | $16 | $18 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $123 | $102 | $97 | $84 |
| Retained Earnings | -$135 | -$115 | -$89 | -$69 |
| AOCI | $3 | $3 | $4 | $2 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$8 | -$10 | $12 | $18 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $6 | $22 | $28 | $36 |
| Net Debt | -$4 | -$1 | -$3 | -$6 |